FIELD: chemistry.
SUBSTANCE: invention relates to a method of producing enantiomeric excess of asymmetrically alkynylated α-aminoesters of formula (III) in which R1 and R2 independently denote C1-7-alkyl, optionally substituted with phenyl or trimethylsilyl, or C3-5-cycloalkyl; Y denotes H or a nitrogen atom protecting group. The method involves reaction of α-iminoester of formula (I), in which R1 and Y assume values given for formula III, with an alkyl containing a terminal triple bond, of formula (II), in which R2 assumes values given for formula III, in the presence of a catalyst. The catalyst used contains a transition metal complex CuPF6·4MeCN or CuOTf·0.5C6H6 and a chiral ligand selected from
, enantiomers thereof and mixture of enantiomers thereof.
EFFECT: method provides high output of asymmetrically alkynylated α-aminoesters of formula (III), which can be used in synthesis as optically active derivatives of amino acids which do not occur naturally.
3 cl, 3 tbl, 4 ex
Title |
Year |
Author |
Number |
ANTIFIBROUS PYRIDINONES |
2015 |
- Ramfal Dzhonni I.
- Bakmen Bred Ouen
- Emayan Kumarasvami
- Nikolas Dzhon Bimond
- Sejvert Skott D.
|
RU2692485C2 |
POSITIVE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTOR |
2012 |
- Eskildsen Jergen
- Sams Anette Graven
- Pjushl Ask
|
RU2604737C2 |
COMPLEXES |
2015 |
- Jon Deangelis, Andrew
- Colacot, Thomas
|
RU2684934C2 |
ANTAGONISTS OF SPHINGONSINE-1-PHOSPHATE (S1P) RECEPTOR AND METHODS OF THEREOF APPLICATION |
2009 |
- Nguen Fong Kh.
- Khejdel'Bau Tod M.
- Chou Ken
|
RU2505527C2 |
SPIRO OXINDOLE MDM2 ANTAGONISTS |
2010 |
- Van Shaomehn
- Juj Shankhaj
- Sun' Vehj
- Kumar Sandzheev
- Sun' Dusin'
- Tszou Pehn
- Chzhao Jujtszjun'
- Makichern Donna
|
RU2553269C2 |
TETRAHYDROISOQUINOLINE COMPOUND, ITS PRODUCTION METHOD, PHARMACEUTICAL COMPOSITION CONTAINING SUCH A COMPOUND, AND ITS USE |
2019 |
- Xu, Yechun
- Liu, Hong
- Tang, Wei
- Zhang, Xianglei
- Gu, Zhanni
- Li, Heng
- Han, Xu
- Zhu, Fenghua
- Feng, Chunlan
- Dong, Guangyu
- Chen, Tiantian
- Chen, Wuyan
- Jiang, Hualiang
- Chen, Kaixian
|
RU2792034C2 |
HETEROCYCLIC AMIDE COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PREPARATION AND USE THEREOF |
2020 |
- Duan, Wenhu
- Geng, Meiyu
- Zhang, Huibin
- Xie, Zuoquan
- Zhou, Jinpei
- Yang, Yifei
- Wang, Xiyuan
- Yang, Xiaojun
- Zhang, Yan
- Hu, Zhaoxue
- Ding, Jian
|
RU2823875C1 |
CHIRAL DIACYLHYDRAZINE LIGANDS FOR MODULATION OF EXOGENOUS GENES EXPRESSION BY ECDYSONE-RECEPTOR COMPLEX |
2013 |
|
RU2640807C2 |
METHODS FOR PRODUCTION OF RACEMIC AMINOSUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE OR RACEMIC AMINOSUBSTITUTED 5,6,7,8-TETRAHYDROISOQUINOLINE, METHODS FOR SEPARATION AND RACEMIZATION THEREOF, METHODS FOR PRODUCTION OF KETOSUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE OR KETOSUBSTITUTED 5,6,7,8-TETRAHYDROISOQUINOLINE, METHOD FOR PRODUCTION OF ENANTIOMER PF CONDENSED BYCYCLIC RING SUBSTITUTED WITH PRIMARY AMINE, 5,6,7,8-TETRAHYDROQUINOLINE DERIVATIVES |
2002 |
- Makichern Ehrnest Dzh.
- Bridzher Gari Dzh.
- Skupinska Kristina A.
- Skerldzh Renato T.
|
RU2308451C2 |
IMIDAZOQUINOLINE SUBSTITUTED PHOSPHORIC ACID ESTER AS AGONIST, ITS PREPARATION AND USE |
2020 |
- Lv, Binhua
- Cui, Dawei
- Chai, Chuanke
- Liu, Ruifeng
- Sheng, Zelin
|
RU2812182C1 |